Dimensional Fund Advisors’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.58M | Sell |
582,279
-34,355
| -6% | -$447K | ﹤0.01% | 2379 |
|
|
2025
Q1 | $6.53M | Sell |
616,634
-90,770
| -13% | -$962K | ﹤0.01% | 2413 |
|
|
2024
Q4 | $12M | Sell |
707,404
-85,196
| -11% | -$1.45M | ﹤0.01% | 2229 |
|
|
2024
Q3 | $18.4M | Sell |
792,600
-125,622
| -14% | -$2.92M | ﹤0.01% | 2039 |
|
|
2024
Q2 | $22.4M | Sell |
918,222
-185,598
| -17% | -$4.52M | 0.01% | 1908 |
|
|
2024
Q1 | $37.3M | Buy |
1,103,820
+14,890
| +1% | +$503K | 0.01% | 1657 |
|
|
2023
Q4 | $34.3M | Buy |
1,088,930
+115,087
| +12% | +$3.63M | 0.01% | 1686 |
|
|
2023
Q3 | $24.9M | Buy |
973,843
+278,989
| +40% | +$7.13M | 0.01% | 1804 |
|
|
2023
Q2 | $19.9M | Buy |
694,854
+208,233
| +43% | +$5.97M | 0.01% | 1929 |
|
|
2023
Q1 | $11.7M | Buy |
486,621
+183,760
| +61% | +$4.4M | ﹤0.01% | 2164 |
|
|
2022
Q4 | $5.14K | Buy |
302,861
+159,743
| +112% | +$2.71K | ﹤0.01% | 2440 |
|
|
2022
Q3 | $2.12M | Sell |
143,118
-6,274
| -4% | -$92.9K | ﹤0.01% | 2698 |
|
|
2022
Q2 | $2.35M | Sell |
149,392
-68,180
| -31% | -$1.07M | ﹤0.01% | 2698 |
|
|
2022
Q1 | $5.87M | Buy |
217,572
+142,633
| +190% | +$3.85M | ﹤0.01% | 2491 |
|
|
2021
Q4 | $2.77M | Buy |
+74,939
| New | +$2.77M | ﹤0.01% | 2759 |
|